JL
Therapeutic Areas
Advanced Bifurcation Systems Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ABS Side-branch Access Stenting System (ABS MD-SBA) | Coronary Bifurcation Lesions (Percutaneous Coronary Intervention) | FDA Breakthrough Device Designation |
| ABS Two Stent System (ABS MD-BI) | Coronary Bifurcation Lesions (Percutaneous Coronary Intervention) | Pre-Clinical |
Leadership Team at Advanced Bifurcation Systems
DM
Dr. Mehran Khorsandi
Chairman, Chief Executive Officer & Co-Founder
HB
Henry Bourang
President, Chief Operating Officer & Co-Founder
KR
Ken Richards
Chief Administrative Officer & Chief Financial Officer
RF
Richard Ferrari
Vice Chairman, Board of Directors
EN
Erin Nagle
Director, Board of Directors
PP
Peter Park
Director, Board of Directors
SY
Susan Yashar
Director, Board of Directors
MF
Malia Foley
Director, Board of Directors
AA
Alex Abizaid, MD
Scientific Advisory Board Member
AC
Antonio Columbo, MD
Scientific Advisory Board Member